A Narrative Review on the Management of Severe COVID-19 Infection Using Stem Cell-Based Therapies with a Focus on the Registered Clinical Trials

    February 2024
    Pietro Gentile
    Image of study
    TLDR Stem cell therapies, especially adipose-derived ones, show promise for treating severe COVID-19 and related conditions.
    The narrative review discusses the management of severe COVID-19 infections using stem cell-based therapies, with a focus on registered clinical trials. It highlights the potential use of mesenchymal stem cells (MSCs), particularly adipose-derived MSCs (AD-MSCs), not only in treating COVID-19 but also in addressing related conditions such as hair loss and telogen effluvium linked to the virus. The review suggests that the section on MSCs in COVID-19 could be enhanced by incorporating recent articles and further analysis of these therapies' potential benefits. The authors are encouraged to consider additional references to strengthen their discussion.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 15 results

    Similar Research

    6 / 1000+ results